Cassava Sciences

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-300
-311
EBITDA
-30,059
-31,464
-61,091
-19,623
EBIT
-30,319
-31,723
-61,391
-19,934
Net Income
-27,597
-27,943
6,155
25,043
Net Change In Cash
0
0
0
0
Free Cash Flow
-61,322
-18,313
-18,270
-19,127
Cash
128,574
148,978
207,291
124,169
Basic Shares
46,604
47,976
46,202
44,102

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$-1
$0
Gross Profit
-89,423
-1
-534
EBITDA
-95,687
-78,719
-32,334
EBIT
-97,217
-80,020
-32,868
Net Income
-24,342
-97,217
-72,472
-31,802
Net Change In Cash
0
0
-1
0
Cost of Revenue
139,931
Free Cash Flow
-117,032
-82,439
-80,226
-52,410
Cash
128,574
121,136
201,015
233,437
Basic Shares
46,604
41,932
40,202
39,405

Earnings Calls

Quarter EPS
2024-12-31
-$0.57
2024-09-30
-$0.58
2024-06-30
$0.13
2024-03-31
$0.58